We report the chemical synthesis of a series of disaccharides of arabinofuranose with a glycosidic sulfur linker as mimics of the acceptor for arabinofuranosyltransferases with and without using any activator to avoid any complex reactions. These analogs were tested for in vitro activity against MTB strain H37Ra and 3 MAC clinical isolates. MICs were determined using a colorimetric microdilution broth assay. Bactericidal activity was studied with kill curves over a period of seven days. Intracellular activity against MTB H37Ra was determined in the Mono Mac 6 (MM6) human monocytic cell line.
Introduction
The resurgence of tuberculosis in developed nations as well as the appearance of multiple drug resistant forms of the disease throughout the world has raised the concern that this disease may resurface as serious public health problem [1] [2] [3] and this attracted renewed attention in identifying the potent antimycobacterial agents. Also, the effective chemotherapy of persons with AIDS who are infected with Mycobacterium avium can be difficult due to the inherent resistance of this organism. 4 All Mycobacterium species share a characteristic cell wall, thicker than in many other bacteria, which is hydrophobic, waxy, and rich in mycolic acids/mycolates. The cell wall consists of the hydrophobic mycolate layer and a peptidoglycan layer held together by a polysaccharide, arabinogalactan. The cell wall makes a substantial contribution to the hardiness Scheme 1. Attempted synthesis of thio-linked disaccharides.
The octyl (3a), 1-methylpropyl (sec-butyl) (3b) and 3-phenylpropyl (3c) arabinosides were obtained separately from methyl-2,3,5-tri-O-benzoyl--D-arabinofuranoside 15 (1) through the glycosyl bromide (2) 16 with SnCl4 17 (Scheme 2). Another two-step protection/deprotection sequence yielded 6 which on reaction with potassium thioacetate gave 7. Compound 7 upon treatment with sodium methoxide and coupling with 2 using mercuric cyanide as an activator afforded 8 in good yield. The target compounds 9a-c were obtained after debenzoylation of 8.
Compound 10 was obtained on treating 1 15 with thiolacetic acid in boron trifluoride etherate which upon reaction with sodium methoxide gave 11 (Scheme 3). The coupling of 11 and 12 (obtained from 6a on refluxing with sodium iodide in 2-butanone) on displacing the iodide of 12 without using any activator and followed by acetylation did not yield the expected -linked thio disaccharide but -linked arap(S,1-5) araf (13) and araf(S,1-5) araf (14) .
Scheme 7. Synthesis of the thio-linked disaccharides 42 and 43.
Compound 37 was refluxed with sodium azide to yield 44 which upon acetylation gave 45. The -thioacetate 46 was obtained from 45 with thiol acetic acid which ultimately yielded 47 with sodium methoxide. The coupling of 47 and 6a gave the expected disaccharides 48 and 49 as octylglycosides after acetylating the residue. The deacetylation of isolated -and -linked thiodisaccharides 48 and 49 yielded 50 and 51 respectively. Compound 49 upon treatment with triphenylphosphine in water followed by deacetylation gave 5-acetamidothiodisaccharide 52 (Scheme 8). b The macrophage viability was reduced by 39% of the control at this concentration. The LD50 for uninfected macrophages was >48 µg/ml. c Significant response (P <0.001).
Compound 9 was active against M. tuberculosis with an MIC that was comparable to that observed with ethambutol. However, the thio-linked arabinofuranosyl disaccharide derivatives examined in this study tended to be less active against M. avium. Compound 9 was also bactericidal for M. tuberculosis and showed significant intracellular activity in a human macrophage cell line. However, the concentration of 9 that was active intracellularly also lowered the viability of the infected macrophages by 39%. The possible contribution of this loss of macrophage viability to the decrease in viability of the intracellular M. tuberculosis is unclear. We have observed that when there is significant decrease in macrophage viability, M. tuberculosis viability can also be affected. Therefore, the CFU reduction may not have been due to the drug alone.
Experimental Section
General. The general procedures were same as reported earlier. 20 The solvent used in NMR is CDCl3 unless otherwise stated. The structures of disaccharides were assigned on the basis of decoupling experiments in 1 H NMR.
Octyl--D-arabinofuranoside (4a).
To a solution of 2 16 (19.0 g, 36. 1 mM) obtained from 1 15 , in CH3CN (600 mL) was added n-octanol (10 mL, 63.5 mM) and SnCl4 (10 mL, 85.5 mM). The reaction mixture was stirred under argon at room temp. After 15h the reaction mixture was diluted with sat NaHCO3 (127 mL) and filtered through a celite pad. To the filtrate was added CHCl3 (260 mL) and water (260 mL). The aqueous layer was extracted thrice with CHCl3. The combined organic layers were washed with aq. NaHCO3, water, dried (MgSO4), filtered, and concentrated under reduced pressure to give crude yellow oil. Purification through a short column of silica gel (cyclohexane : EtOAc, 4 : 1) gave 3a (14 g ) as a yellow oil. A solution of 3a (4.69 g, 8. 17 mM) in dry MeOH (36 mL) was treated with methanolic ammonia (7N, 36 mL) under an atmosphere of argon. After 22 h at room temp the reaction mixture was concentrated under reduced pressure followed by column chromatography (CHCl3 : MeOH, 9.5 : 0.5) gave 4a, (5.30 g, 56 % for the last two steps). FAB-MS : m/z 263(M+H) + . 1 HNMR :  5.01 (1H, s, H-1), 4.16 (1H, dd, J 4.2, 1.9 Hz, 4.01 (2H, m, 3.89 (1H, dd, J 11.8, 2.4 Hz, 3.82 (1H, dd, J 11.8, 1.76 Hz, H-5b), 3.71 (1H, m, OCHH-(CH2)6CH3), 3.44 (1H, m, OCHH-(CH2)6CH3), 1.59 (2H, m, OCHH-CH2(CH2)5CH3), 1.27 (10H, m, OCHH-CH2(CH2)5CH3), 0.88 (3H, t, J 7.0 Hz, OCHH-CH2(CH2)5CH3). (5a) . Compound 4a (6.39 g, 24.4 mM) in anhydrous pyridine (30 mL) was cooled to 0 o C and added drop wise a solution of ptoluenesulphonyl chloride (5.11 g, 26.8 mM) . After 24 h at room temperature, the mixture was poured into ice water (83 mL), and extracted twice with CH2Cl2. The combined organic layers were washed successively with 1N HCl, aq. NaHCO3, water, dried (MgSO4), filtered, and concentrated to give crude yellow oil. Purification by silica gel chromatography (cyclohexane : C, the course of the reaction being monitored by T.L.C. The solvent was removed by passing argon into the mixture. To the residue was added dry benzene (34mL) and nitromethane (34 mL). The volume was reduced by half under reduced pressure. Then a solution of 2 (2.27 g, 4.3 mM) in benzene (5 mL) and nitromethane (5mL) was added, followed by Hg(CN)2 (1.08 g, 4.3 mM) and 4 A 0 molecular sieves. The cloudy white reaction mixture was stirred for 40 h at 65 o C, under an atmosphere of argon, with exclusion of moisture and light. The reaction mixture was allowed to cool, diluted with CHCl3 (24mL), and filtered through a bed of celite. The filtrate was washed with water, aq. NaHCO3, aq. NaCl, dried (MgSO4), filtered, and concentrated to give crude yellow foam. Purification by silica gel chromatography (cyclohexane : EtOAc, 3 : 1) gave 0.28 g (15%) of 8a as a yellow oil. FAB-MS (0.18 g, 0. 25 mM) in dry chloroform (2 mL) and dry methanol (1.5 mL) was added a solution of sodium metal (10 mg) in dry methanol (1 mL). The reaction mixture was stirred under an atmosphere of argon. After 36h at room temperature, the reaction mixture was diluted with water (6 mL) and neutralized with Dowex-50W (50X8-400) cation exchange resin. The mixture was filtered through a cintered glass funnel and the filtrate partitioned between chloroform and water. The aqueous layer was washed with chloroform and then concentrated under reduced pressure. The white residue was purified by silica gel chromatography (CHCl3 : MeOH 
Octyl-5-O-p-toluenesulfonyl--D-arabinofuranoside

1-Methylpropyl--D-arabinofuranoside (4b).
A solution of 3b (3.29 g, 6.35 mM) in dry methanol (28 mL) was treated with methanolic ammonia (7N, 28 mL) under an atmosphere of argon as reported earlier in 4a to give 4b (1.3 g) as a yellow oil. The material was used directly in the next step.
1-Methylpropyl-5-O-p-toluenesulfonyl--D-arabinofuranoside (5b).
Compound 4b (1.3 g, 6 .31 mM) in anhydrous pyridine (9.3 mL) was cooled to 0 o C and added drop wise a solution of p-toluenesulphonyl chloride (1.30 g, 6.82 mM) as mentioned earlier in 5a to give a crude yellow oil. Purification by silica gel chromatography (cyclohexane : EtOAc, 1 : 1) gave 5b as diastereomers (1.4 
1-Methylpropyl-2,3-di-O-acetyl-5-O-p-toluenesulfonyl--D-arabinofuranoside (6b).
To an ice cold solution of 5b (1.62 g, 4.50 mM) in pyridine (8 mL) was added drop wise Ac2O (7.3 mL) as done in 6a to give a crude oil. Purification by silica gel chromatography (cyclohexane/EtOAc, 3 : 1) gave 1 
1-Methylpropyl-5-deoxy-5-S-(-D-arabinofuranosyl)-5-thio--D-arabinofuranoside (9b).
To a solution of 8b (0.649 g, 0.97 mM) in dry chloroform (7 mL) and dry MeOH (7 mL) was added a solution of sodium metal (60 mg) in dry MeOH (4 mL) as in 9a followed by gel chromatography (CHCl3 : MeOH 
3-Phenylpropyl--D-arabinofuranoside (4c).
A solution of 3c (6.7 g, 11.5 mM) in 51 mL of dry MeOH was treated with methanolic ammonia (7N, 51 mL) as reported in 4a to give 3.0 g (quant.) of 4c as a yellow oil. The material was used directly in the next step. 
1-Thioacetyl-2,3,5-tri-O-benzoyl-1-thio--D-arabinofuranoside (10). Compound 1
15 (500 mg, 1.05 mM) was dissolved in anhydrous CH2Cl2 (10 mL), thiolacetic acid (71 L, 0.99 mM) was added drop wise followed by BF3OEt2 (0.66 mL, 5.25 mM) at room temperature under the atmosphere of argon. The reaction mixture was stirred overnight at room temperature. Aq. NaHCO3 was added to it and reaction mixture was extracted twice with CH2Cl2. The organic layer was washed with water, dried over Na2SO4, filtered and concentrated under reduced pressure. Column chromatography (cyclohexane : EtOAc, 9.5 : 0. (12) . A solution of NaI (840 mg, 5.6 mM) and 6a (400 mg, 0.8 mM) in 2-butanone (10 mL) was refluxed for 5 h. The reaction mixture was cooled to ambient temperature and filtered through a pad of celite. The filtrate was concentrated in reduced pressure and residue was partitioned between CH2Cl2 and water. The organic layer was washed with aq. Na2S2O3 (0.1N), water, dried over Na2SO4, filtered and concentrated to give a clear oil. Column chromatography (cyclohexane : EtOAc, 9.5 : 0. (14) . To a solution of 10 (103 mg, 0.2 mM) in anhydrous MeOH (5 mL), freshly prepared solution of MeONa (1M, 0.2 mL) was added drop wise at -78 0 C under argon. After 1h at room temperature, TLC confirmed the completion of the reaction. MeOH was evaporated off by gently passing the argon through the flask. The resulting residue 11 was dried overnight in vacuum pump. The residue 11 and iodo sugar, 12 (76 mg, 0.16 mM) were dissolved separately in dry DMF (5mL each) and mixed together slowly at room temperature under the atmosphere of argon. The reaction mixture was stirred for 48 h at room temperature. DMF was evaporated off under reduced pressure. The residue was taken in CH2Cl2, washed with aq. NaHCO3, water, dried over Na2SO4, filtered and concentrated to thick syrup. The syrup was acetylated with dry pyridine (3 mL) and Ac2O (3 mL) followed by usual work up and column chromatography (cyclohexane : EtOAc, 9 : 1 to 8 : 2) gave 13 (30 mg, 25%) and 14 (20 mg, 16%). (19) . To a solution of 17 (230 mg, 0.48 mM) in anhydrous MeOH (5 mL), freshly prepared solution of MeONa (1M, 0.5 mL) was added drop wise at -78 0 C as reported in 13 and 14 to give thiosodium 18. The residue 18 and tosyl derivative 6a (250 mg, 0.5 mM) were dissolved separately in dry DMF (5 mL each) and mixed together slowly at room temperature as done in 13 and 14. Column chromatography (cyclohexane : EtOAc, 9.5 : 0.5 to 9 : 1) of the residue gave 19 (42 mg, 12%). 
Octyl-2,3-di-O-acetyl-5-deoxy-5-iodo--D-arabinofuranoside
Octyl-2,3-di-O-acetyl-5-S-(2,3,4-tri-O-acetyl--D-arabinopyranosyl)-5-thio--D-arabinofuranoside (13) and Octyl-2,3-di-O-acetyl-5-S-(2,3,5-tri-O-acetyl--D-arabinofuranosyl)-5-thio--D-arabinofuranoside
: FAB-MS
Octyl-2,3-di-O-acetyl-5-S-(2,3,5-tri-O-benzyl--D-arabinofuranosyl)-5-thio--D-arabinofuranoside
Methyl-2,3,5-tri-O-methyl--D-arabinofuranoside (20). Compound 15
18 (1.73 g, 10.59 mM) was dissolved in dry DMF (50 mL) and NaH (60% dispersion in mineral oil, 2.12 g, 53 mM) was added. The reaction mixture was stirred at room temperature for 30min followed by addition of iodomethane (3.62 mL, 58.24 mM) dropwise at 0 ºC and stirred for 4 h at room temperature. MeOH (20 mL) was added, the solution was concentrated to dryness, the oil was redissolved in CH2Cl2 and organic layer was washed with water, brine, dried over Na2SO4, filtered and concentrated under reduced pressure. The residue was chromatographed (cyclohexane : EtOAc, 9 : 1) to yield 20 (1.29 g, 60% 
Octyl-2,3-di-O-acetyl-5-S-(2,3,5-tri-O-methyl--D-arabinofuranosyl)-5-thio--D-arabinofuranoside (25)
. To a solution of 22 (275 mg, 1.1 mM) in anhydrous MeOH (5 mL), freshly prepared solution of MeONa (1M, 1.1 mL) was added drop wise at -78 0 C as reported in 13 and 14 to give thiosodium 24. The residue 24 and tosyl derivative 6a (550 mg, 1.1 mM) were dissolved separately in dry DMF (2mL each) and mixed together slowly at room temperature as done in 13 and 14. Column chromatography (cyclohexane : EtOAc, 9 : 1 to 8.5 : 1.5) of the residue gave 25 (275 mg, 47%). Similarly, compound 21 (100 mg, 0.4 mM) was reacted with MeONa to give 23 which on coupling with 6a (205 mg, 0. 3.412, 3.411, 3.399 (3H, s, 3 × OMe), 3.16 (1H, dd, J 14.1, 4.7 Hz, H-5a), 2.88 (1H, dd, J 14.1, 5.7 Hz, H-5b), 2.09, 2.08 (3H, s, 2 × OAc), 1.57 (2H, m, -OCH2CH2(CH2)5CH3), 1.27 (10H, m, -OCH2CH2(CH2)5CH3), 0.88 (3H, t, J 6.3 Hz, -OCH2CH2(CH2)5CH3). (Found : C, 56.01, H, 8.12. C25H44O10S required C, 55.95, H, 8.26 ).
Octyl-5-S-(2,3,5-tri-O-methyl--D-arabinofuranosyl)-5-thio--D-arabinofuranoside. (26).
Compound 25 (104 mg, 0.19 mM) was dissolved in dry MeOH ( 2mL) and methanolic ammonia (7N, 2 mL) was added to it. The reaction mixture was stirred overnight at room temperature and solvents were evaporated under reduced pressure. Column chromatography (cyclohexane : EtOAc, 7 : 3 to 6 : 4) of the residue gave 26 (61 mg, 70%). 
Methyl-2,3-di-O-methoxybenzyl-5-O-t-butyldiphenylsily--D-arabinofuranoside
(28). Compound 27 19 (5.22 g, 12. 97 mM) was added to a suspension of NaH (60% dispersion in mineral oil, 1.24 g, 31.05 mM) in dry DMF (40 mL) drop wise at 0 0 C followed by methoxybenzylchloride (4.22 mL, 31.05 mM) and tetrabutylammonium bromide (1 g). The reaction mixture was stirred overnight at room temperature and was worked up as reported in 20. The residue was column chromatographed (cyclohexane : EtOAc, 1 : 1) to yield 28 (3.7 g, 45%) .  7.31 (5H, m, BnH), 7.19 (4H, m, methoxyBnH, ortho), 6.84 (4H, m, methoxyBnH, meta), 4.92 (1H, s, 4.55 (2H, m, 4.43 (4H, m, 4.17 (1H, m, 3.94 (1H, dd, J 2.8, 1.1 Hz, 3.85 (1H, dd, J 6.4, 2.7 Hz, 3.80, 3.78 (3H, s, 2 × OMe), 3.58 (2H, m, b) , 3.38 (3H, s, -OMe).
Methyl-2,3-di-O-acetyl-5-O-benzyl--D-arabinofuranoside (32)
. Ceric ammonium nitrate (2.65 g, 4.84 mM) was added to 30 (600 mg, 1.21 mM) in CH3CN : H2O (9 : 1, 20 mL) at room temperature. After 4 h, the reaction was diluted with aq. NaHCO3 and extracted with CH2Cl2 twice. The organic layer was washed with brine, dried (Na2SO4), filtered and concentrated under reduced pressure to give 31. Acetylation of 31 with pyridine (3 mL) and Ac2O (3 mL) followed by usual work up and column chromatography (cyclohexane : EtOAc, 9 : 1 to 8 : 2) yielded 32 (280 mg, 91%). FAB-MS m/z 345 (M+Li) + ; 1 HNMR  7.30 (5H, m, BnH), 5.08 (1H, m, 5.04 (1H, d, J 1.3 Hz, 4.94 (1H, s, 4.61 (2H, m, 4.20 (1H, m, 3.77 (1H, dd, J 10.8, 3.3 Hz, 3.70 (1H, dd, J 10.8, 5.3 Hz, , 3.40 (3H, s, -OMe), 2.08, 2.04 (3H, s, 2 × OAc).
1-Thioacetyl-2,3-di-O-acetyl-5-O-benzyl-1-thio--D-arabinofuranoside (33).
Compound 32 (260mg, 0.76mM) was dissolved in anhydrous CH2Cl2 (10ml), thiolacetic acid (75L, 1.01mM) was added drop wise followed by BF3OEt2 (0.71mL, 5.7mM) at room temperature as reported in 10. The residue was column chromatographed (cyclohexane : EtOAc, 9.1) to give 33 (191mg, 65%) as a colorless syrup. FAB-MS m/z 389 (M+Li) + ; 1 HNMR  7.30 (5H, m, BnH), 6.03 (1H, s, H-1), 5.22 (1H, t, J 1.43Hz, H-2), 5. 16 (1H, dd, J 4.3, 1Hz, 4.59 (2H, m, 4.22 (1H, m, 3.72 (2H, d, J 4.6Hz, b) , 2.38 (3H, s, -SAc), 2.11, 2.01 (3H, s, 2 × OAc). (5 mL), freshly prepared solution of MeONa (1M, 0.46 mL) was added drop wise at -78 0 C as reported in 13 and 14 to yield 34. The residue 34 and tosyl derivative 6a (230 mg, 0.46 mM) were dissolved separately in dry DMF (2 mL each) and mixed together slowly at room temperature as done in 13 and 14. The syrup was acetylated with pyridine (3 ml) and Ac2O (3 mL) followed by usual work up and column chromatography (cyclohexane : EtOAc, 9 : 1 to 8.5 : 1.5) gave 35 (47 mg, 15%) and 36 (36 mg, 12%). 18 (1.5 g, 9.15 mM) was added dropwise a solution of p-toluenesulfonyl chloride (1.92 g, 10.06mM) in pyridine (10 mL) at 0 ºC and the reaction mixture was stirred at room temperature overnight as mentioned earlier in 5 to give a crude pale oil. Purification by silica gel chromatography (CH2Cl2 : MeOH, 9.5 : 0.5 to 9 : 1) gave 37 (1.72 , freshly prepared solution of MeONa (1M, 0.9 mL) was added drop wise at -78 0 C as reported in 13 and 14 to yield 41. The resulting residue 41 and tosyl derivative 6a (430 mg, 0.86 mM) were dissolved separately in dry DMF (5 mL each) and mixed together slowly at room temperature as done in 13 and 14 to give crude syrup which was acetylated with pyridine (3 ml) and Ac2O (3 mL) followed by usual work up and column chromatography (cyclohexane : EtOAc, 9 : 1 to 8.5 : 1.5) gave 42 (45 mg, 9%) and 43 (76 mg, 16%). . NaN3 (572 mg, 8.8 mM) was added to a solution of 37 (700 mg, 2.2 mM) in dry DMF (10 mL) at room temperature. The reaction was heated to 100 0 C for 6 h followed by evaporation of DMF under reduced pressure. The residue was extracted with acetone : ether (2 : 1, 10 mL) thrice and filtered. The filtrate was evaporated to dryness under reduced pressure by coevaporating with pyridine thrice to give 44. Acetylation of 44 with pyridine (5 mL) and Ac2O (5 mL) followed by usual work up and column chromatography (cyclohexane : EtOAc, 9 : 1 to 8 : 2) yielded 45 (420 mg, 70%). (49) . To a solution of 46 (250 mg, 0.79 mM) in anhydrous MeOH (7 mL), freshly prepared solution of MeONa (1M, .0.8 mL) was added drop wise at -78 0 C as reported in 13 and 14 to yield thiosodium 47. The resulting residue 47 and tosyl derivative 6a (395 mg, 0.79 mM) were dissolved separately in dry DMF (5 mL each) and mixed together slowly at room temperature as done in 13 and 14 to give crude syrup which was acetylated with pyridine (3 mL) and Ac2O ( 3mL) followed by usual work up and column chromatography (cyclohexane : EtOAc, 9 : 1 to 8.5 : 1.5) gave 48 (24 mg, 9%) and 49 (37 mg, 12%) beside recovering the tosyl derivative 6a (168 mg). Hz, H-5a), 2.94 (1H, dd, J 14.1, 5.6 Hz, H-5b), 2.12, 2.11, 2.10, 2.09 (3H, s, 4 × OAc), 1.58 (2H, m, -OCH2CH2(CH2)5CH3), 1.27 (10H, m, -OCH2CH2(CH2)5CH3), 0.88 (3H, t, J 6.4 Hz, -OCH2CH2(CH2)5CH3). (Found : C, 51.50, H, 6.74, N, 7.10. C26H41N3O11S required C, 51.73, H, 6.84, N, 6.96 
